Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX)

CUSIP: 01438T106

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
59,794,743
Total 13F shares
34,234,495
Share change
-3,268,716
Total reported value
$131,165,420
Put/Call ratio
6.8%
Price per share
$3.83
Number of holders
121
Value change
-$14,803,182
Number of buys
68
Number of sells
53

Quarterly Holders Quick Answers

What is CUSIP 01438T106?
CUSIP 01438T106 identifies ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q2 2025

As of 30 Jun 2025, Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) was held by 121 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,234,495 shares. The largest 10 holders included Knoll Capital Management, LLC, PERCEPTIVE ADVISORS LLC, BlackRock, Inc., VANGUARD GROUP INC, ARDSLEY ADVISORY PARTNERS LP, AQR CAPITAL MANAGEMENT LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., GEODE CAPITAL MANAGEMENT, LLC, 683 Capital Management, LLC, and STATE STREET CORP. This page lists 120 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.